Langabeer, S., Haslam, K., Crampe, M., MacDonagh, B., & McHugh, J. (2023). Suboptimal molecular response to tyrosine kinase inhibition associated with acquisition of a T240A ABL1 kinase domain mutation in a patient with chronic myeloid leukemia. PH Akademperiodyka.
Chicago-Zitierstil (17. Ausg.)Langabeer, S.E, K. Haslam, M. Crampe, B. MacDonagh, und J. McHugh. Suboptimal Molecular Response to Tyrosine Kinase Inhibition Associated with Acquisition of a T240A ABL1 Kinase Domain Mutation in a Patient with Chronic Myeloid Leukemia. PH Akademperiodyka, 2023.
MLA-Zitierstil (8. Ausg.)Langabeer, S.E, et al. Suboptimal Molecular Response to Tyrosine Kinase Inhibition Associated with Acquisition of a T240A ABL1 Kinase Domain Mutation in a Patient with Chronic Myeloid Leukemia. PH Akademperiodyka, 2023.